In patients with heart failure (HF) due to acute myocardial infarction (AMI), angiotensin ... standard treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers ...

Heart Failure, Pathophysiology, Etiology, Reduced Ejection Fraction, Preserved Ejection Fraction, Revascularization, CABG, ...

[30] There was no difference in the primary end point, fatal coronary heart disease, or nonfatal myocardial infarction ... or an angiotensin-converting enzyme inhibitor. Such therapy, although ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

TIMI Study Group: The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312: 932–6 CrossRef MEDLINE 12. Turer AT, Mahaffey KW, Gallup D, et al.: ...

University of Virginia School of Medicine researchers have discovered how long-term treatment of high blood pressure with ...

Epcoritamab-bysp showed a 69% objective response rate and 62% complete response rate in older patients with large B-cell ...

Million Senior Secured Term Loan Credit Facility and New $100 Million Convertible Note to Repay Significant Portion of Existing $265 ...

A new study published in the Journal of Clinical Endocrinology and Metabolism showed that among type 2 diabetes mellitus ...

The effectiveness of early thrombolysis in the management of acute myocardial infarction (AMI) is well established ... 1– 5 Thrombolytic agents eliminate the obstruction by activating the enzyme, ...

ST-elevation myocardial infarction (STEMI) following successful primary percutaneous ... and significantly increased serum myocardial enzyme and troponin concentrations. Written informed consent was ...

These enzymes promote inflammation ... Additionally, there are higher rates of lymphomas and lung cancers, MACE (cardiovascular death, myocardial infarction, and stroke), and thrombosis (pulmonary ...